Lifespan Edge, a longevity-focused wellness company, has opened its second location in Dorado, Puerto Rico, following sustained demand at its Texas clinic. The expansion reflects growing interest in Therapeutic Plasma Exchange protocols, which filter inflammatory proteins and damaged molecules from the bloodstream to support healthier aging. The company plans to open at least two additional locations in early 2026, including a Florida launch anticipated in late Q1 or early Q2.
Therapeutic Plasma Exchange is a clinically established procedure that replaces harmful circulating factors with a clean albumin solution. While traditionally used to treat autoimmune and neurological conditions, TPE is now emerging in longevity science, where research suggests reducing inflammatory and age-related factors may help reset the body at a systemic level. This approach aims to support improved cognition, immune function, and overall resilience, shifting focus from merely extending lifespan to enhancing healthspan.
"Longevity is shifting from a concept to a clinical conversation," said Dr. Michael Roizen, physician, CEO and co-founder of Lifespan Edge. "People are asking better questions earlier, and they're looking for physician-guided strategies that are grounded in biology. Therapeutic Plasma Exchange is one of the interventions drawing attention because it's measurable, it's medically supervised, and it aligns with the broader goal of improving healthspan, not just lifespan." The expansion into Puerto Rico taps into the region's emergence as a destination for wellness innovation and preventative health services, serving both local residents and those traveling specifically for longevity care.
The Dorado location follows the success of the company's Texas clinic, which has remained fully booked as interest grows in evidence-informed longevity interventions. "Our Texas location demonstrated strong demand from people who want to be proactive about aging," said Justin Yeo from Lifespan Edge. "Dorado is a natural next step as we serve both the local community and those who travel specifically for wellness and longevity care." For more information about Lifespan Edge's clinical services and locations, visit https://www.lifespan-edge.com.
This expansion matters because it represents the commercialization of longevity science, moving beyond theoretical discussions to clinically supervised interventions. As populations age globally, the implications for healthcare systems, individual wellness, and economic productivity are substantial. The growth of services like TPE signals a shift toward preventative, proactive health strategies that could reduce age-related disease burden and improve quality of life in later years. For the industry, it highlights increasing consumer demand for measurable, science-backed interventions and the potential for new clinical partnerships, as indicated by the company's invitation to physicians to learn about their partnership program at the https://www.functionallongevitysummit.com in Phoenix, Arizona.
